Adicet Bio
ACET
49 hedge funds and large institutions have $56.6M invested in Adicet Bio in 2025 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 21 increasing their positions, 8 reducing their positions, and 20 closing their positions.
367% more call options, than puts
Call options by funds: $14K | Put options by funds: $3K
163% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 8
36% more capital invested
Capital invested by funds: $41.6M → $56.6M (+$14.9M)
0.53% more ownership
Funds ownership: 3.86% → 4.39% (+0.53%)
9% less funds holding
Funds holding: 54 → 49 (-5)
25% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 20
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
+$6.93M |
| 2 |
WP
Woodline Partners
San Francisco,
California
|
+$6.91M |
| 3 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$5.27M |
| 4 |
O
OrbiMed
New York
|
+$3.45M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$3.03M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Tang Capital Management
San Diego,
California
|
-$5.61M |
| 2 |
Millennium Management
New York
|
-$459K |
| 3 |
SSA
Schonfeld Strategic Advisors
New York
|
-$388K |
| 4 |
WIA
Wealthedge Investment Advisors
New York
|
-$243K |
| 5 |
Jane Street
New York
|
-$151K |
ACET Hedge Fund Activity: Q4 2025 in Review
49 of the 8,271 institutional investors tracked by Wall St. Rank reported a position in Adicet Bio (ACET) for Q4 2025, worth a combined $56.6M — up 36% from $41.6M a quarter earlier.
Sellers outnumbered buyers: 20 funds closed out of ACET and 15 opened new positions — a net loss of 5 holders — while 8 trimmed existing stakes and 21 added.
The largest buyer was Franklin Resources, opening a new position worth an estimated $6.93M. The largest seller was Tang Capital Management, cutting an estimated $5.61M.
- 49 institutional investors held Adicet Bio (ACET) as of Q4 2025, down from 54 in Q3 2025.
- Funds reported $56.6M of Adicet Bio stock for Q4 2025, up 36% quarter-over-quarter.
- 15 funds opened new Adicet Bio positions in Q4 2025 and 20 closed out, a net change of -5 holders.
- The largest Adicet Bio buyer in Q4 2025 was Franklin Resources, an estimated $6.93M added.
- The largest Adicet Bio seller in Q4 2025 was Tang Capital Management, an estimated $5.61M sold.
Based on aggregated 13F filings for Q4 2025.